| 陈赞广,雷 林,刘芳江.2010—2020年深圳市前列腺癌发病及变化趋势分析[J].中国肿瘤,2022,31(1):49-54. |
| 2010—2020年深圳市前列腺癌发病及变化趋势分析 |
| The Incidence and Trend of Prostate Cancer in Shenzhen City from 2010 to 2020 |
| 中文关键词 修订日期：2021-09-28 |
| DOI：10.11735/j.issn.1004-0242.2022.01.A005 |
|
 |
| 中文关键词: 前列腺癌 发病率 趋势 广东 |
| 英文关键词:prostate cancer incidence trend Guangdong |
| 基金项目:深圳市医疗卫生三名工程（SZSM201911015） |
|
| 摘要点击次数: 866 |
| 全文下载次数: 175 |
| 中文摘要: |
| 摘 要：［目的］ 分析2010—2020年深圳市前列腺癌发病情况及其变化趋势。［方法］ 整理2010年1月至2020年12月深圳市肿瘤登记报告中的常住户籍人群前列腺癌的发病资料并进行统计分析，计算前列腺癌的粗发病率、35～64岁截缩率、0~74岁累积发病率，并用2000年中国标准人口构成和Segi’s世界标准人口构成进行发病率的标化(中标率和世标率)。应用 Joinpoint 4.9.0.0 软件分析前列腺癌发病率的时间变化趋势，计算年度变化百分比（APC）。［结果］ 深圳市2010—2020年期间共报告前列腺癌1 897例，2010—2020年深圳市前列腺癌粗发病率为9.18/10万，中标率为16.34/10万，世标率为16.29/10万。其中2016—2020年深圳市前列腺癌发病整体呈上升趋势，中标率APC为13.50%(P<0.05)；世标率APC为14.0%(P<0.05)。各个年龄段中，40岁以下发病率极低，40岁后前列腺癌发病率随年龄增长呈上升趋势，80岁以后发病率开始逐渐下降。［结论］ 2010—2020年深圳市前列腺癌的粗发病率、中标率和世标率均呈逐年上升趋势。而且40~80岁年龄段前列腺癌发病率随年龄增长呈上升趋势，应该重点关注中老年男性人群前列腺癌的防治工作。 |
| 英文摘要: |
| Abstract： ［Purpose］ To analyze the incidence and trend of prostate cancer in Shenzhen Ｃity from 2010 to 2020. ［Methods］ The incidence data of prostate cancer among permanent residents in Shenzhen cancer registration areas from January 2010 to December 2020 were collected and analyzed. The crude incidence， truncated rate(35～64 years old) and cumulative incidence rate(0～74 years old) were calculated. The age standardized rates adjusted by Chinese standard population in 2000(ASR China）and world Segi’s standard population(ASR world）were calculated and the age-specific incidence rate was also calculated. The annual percentage change(APC) was calculated by using Joinpoint 4.9.0.0 software. ［Results］ A total of 1 897 cases of prostate cancer were reported in Shenzhen from 2010 to 2020. The crude incidence rate was 9.18/105， with ASR China of 16.34/105 and ASR world of 16.29/105. The overall incidence of prostate cancer in Shenzhen was on the rise. The APC of ASR China from 2016 to 2020 was 13.50%(P＜0.05）and the APC of ASR world was 14.0%(P＜0.05）. In all age groups， the incidence of prostate cancer was very low under age of 40 years. After 40 years old， the incidence of prostate cancer increased with age， and gradually decreased after 80 years of age. ［Conclusion］ From 2010 to 2020， the crude incidence， ASR China and ASR world of prostate cancer in Shenzhen shows an increasing trend. In addition， the incidence of prostate cancer in the age group of 40 to 80 years old is increasing with age， so the prevention and control of prostate cancer in middle-aged and elderly men should be paid more attention. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |